Australia's Vitrafy Life Sciences gains on entering US market

Vitrafy Life Sciences

02/09/2026 04:10

** Shares of Australia's Vitrafy Life Sciences VFY.AX rise as much as 6.7% to A$4.110, hitting their highest level since August 24
** Cell preservation technology developer enters into an agreement with U.S.-based medical products manufacturer Charter Medical
** As per the agreement, VFY will install its cryopreservation ecosystem at Charter's North Carolina cell and gene therapy Innovation Hub
** Adds, agreement, which marks VFY's entry into the U.S. markets, will span an initial 6-month term
** Stock up 212.5% YTD


 (Reporting by Shravya Marakini in Bengaluru)
 ((shravya.marakini@thomsonreuters.com;))